Cigna Investments’s Emergent Biosolutions EBS Stock Holding History

Cigna Investments’s Portfolio EBS Stock Details EBS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q1	–	Sell	-6,955	Closed	-$413K	–	708
2018 Q4	$413K	Sell	6,955 -3,360	-33%	-$217K	0.04%	395
2018 Q3	$631K	Buy	10,315 +260	+3%	+$15.2K	0.05%	288
2018 Q2	$508K	Sell	10,055 -184	-2%	-$9.59K	0.04%	418
2018 Q1	$540K	Sell	10,239 -3,329	-25%	-$166K	0.04%	424
2017 Q4	$630K	Buy	13,568 +8,431	+164%	+$355K	0.04%	376
2017 Q3	$208K	Buy	+5,137	New	+$186K	0.01%	825

Other funds holding EBS

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Neuberger Berman Group New York $131B AUM 28.36% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

RHJA

Rice Hall James & Associates San Diego, California $1.8B AUM 36.16% 1-Year Est. Return

SCM

Snyder Capital Management San Francisco, California $5.16B AUM 26.72% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Cigna Investments's EBS Position: Q1 2019 in Review

Cigna Investments sold out of Emergent Biosolutions (EBS) in Q1 2019, closing a stake of 6,955 shares — an estimated $413K sold.

Cigna Investments first reported a position in EBS in Q3 2017 and held it in 6 quarters. The position peaked at $631K in Q3 2018. 272 funds tracked by Wall St. Rank hold EBS as of Q1 2019.

Cigna Investments reported no remaining Emergent Biosolutions position as of Q1 2019 after selling out during the quarter.
Cigna Investments sold 6,955 Emergent Biosolutions shares in Q1 2019, an estimated $413K.
Cigna Investments first reported a position in Emergent Biosolutions in Q3 2017 and held it in 6 quarters.
Cigna Investments's Emergent Biosolutions position peaked at $631K in Q3 2018.
272 funds tracked by Wall St. Rank held Emergent Biosolutions as of Q1 2019.

Based on Cigna Investments's 13F filing for Q1 2019, filed 10 May 2019.